Management of Basal Cell Carcinoma After Surgical Excision

Introduction to Post-Excision Management

The British Journal of Dermatology recommends long-term clinical surveillance as the standard approach for completely excised basal cell carcinoma, given the low recurrence rate of less than 2% at 5 years 1
For facial lesions, especially those on the nose, which are high-risk areas, monitoring should be more vigilant 1, 2
No adjuvant therapy is necessary after complete excision of basal cell carcinoma 1

For positive or very close margins, re-excision or Mohs surgery are the treatments of choice, especially for critical mid-facial locations like the nose 1, 2, 3
The recurrence rate after incomplete excision varies between 30-41% at 2-5 years of follow-up 1, 3, 4
Re-excision of incompletely excised lesions reveals residual tumor in 45-54% of cases with standard histopathologic examination and in 55% of cases re-excised with Mohs surgery 1, 3, 5
The risk of recurrence is 17% when only lateral margins are involved but increases to 33% when deep margins are involved 1, 2

Location on critical mid-facial areas (including the nose) is an absolute indication for re-treatment 1, 2
Positive deep surgical margin 1, 2
Defect repaired with skin flaps or grafts 1, 2
Aggressive histologic subtype (infiltrative, micronodular, sclerodermiform, morpheaform) 1, 2, 6

For infiltrative, micronodular, sclerodermiform, or morpheaform subtypes, Mohs surgery is the treatment of choice, even if initial margins appear negative, due to unpredictable subclinical extension 6
Mohs surgery achieves cure rates of 99% at 5 years for primary basal cell carcinoma and 94.4% for recurrent disease 3, 4, 5, 6
Aggressive subtypes require wider peripheral margins (5-10 mm or more) even with standard excision, but these margins may still be insufficient without complete margin control 6
Curettage and electrodesiccation should never be used for aggressive histologic subtypes, with reported recurrence rates of 19-27% 6

Step 1: Obtain complete histopathologic report (margins + histologic subtype)
Step 2: Evaluate margin status:
Step 3: For positive margins, evaluate risk factors:

Do not assume all positive margins will recur - only 21-41% recur, but this risk is unacceptable for critical facial locations like the nose 1, 3, 4
Do not underestimate the importance of the deep margin - positive deep margins have a 33% recurrence risk compared to 17% for lateral margins 1, 2
Do not delay re-excision if the defect has already been repaired with a flap - this is a specific indication for re-treatment, not surveillance 1, 2
Do not treat aggressive subtypes like superficial nodular types - they require a more aggressive approach regardless of margin status 6
Be aware that some incompletely excised lesions may demonstrate a more aggressive histologic subtype at recurrence, especially on the central face 1, 2